{
    "Trade/Device Name(s)": [
        "cobas\u00ae Influenza A/B & RSV Nucleic acid test for use on the cobas\u00ae Liat\u00ae System"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K210234",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200065"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OOI",
        "OZE"
    ],
    "Summary Letter Date": "January 26, 2021",
    "Summary Letter Received Date": "January 28, 2021",
    "Submission Date": "January 18, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "Real Time Nucleic Acid Amplification System"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus RNA",
        "Influenza B virus RNA",
        "Respiratory syncytial virus (RSV) RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "cobas\u00ae Influenza A/B & RSV assay tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae Liat\u00ae Analyzer",
        "cobas\u00ae Liat\u00ae System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Multiplex nucleic acid amplification",
        "Silica-magnetic bead-based nucleic acid extraction"
    ],
    "Methodologies": [
        "RT-PCR",
        "Molecular detection",
        "Qualitative multiplex assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Software",
        "Tube",
        "Reagent",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for cobas Influenza A/B & RSV nucleic acid test using real-time RT-PCR on the cobas Liat System for rapid qualitative detection of respiratory viruses",
    "Indications for Use Summary": "Automated multiplex real-time RT-PCR assay for rapid qualitative detection and discrimination of Influenza A, Influenza B, and RSV RNA in nasopharyngeal swab specimens from symptomatic patients, as an aid in differential diagnosis in conjunction with clinical and epidemiological risk factors; not intended to detect Influenza C",
    "fda_folder": "Microbiology"
}